Citius Pharmaceuticals, Inc. (CTXR) › Cost of RevenueCitius Pharmaceuticals, Inc. (CTXR) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $45.0K2017: $50.0K2018: $75.0K$75.0K2016Cost of Revenue (USD)2018Fiscal YearCost of RevenueChange YoY2018$75.0K+50.0%2017$50.0K+11.1%2016$45.0K—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share